Association of adverse outcomes of intrahepatic cholestasis of pregnancy with zonulin levels

References

• Abreu MT. 2010. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nature Reviews Immunology 10:131–144.
   PubMed Web of Science ®Google Scholar
• Bacq Y, Sentilhes L, Reyes HB, Glantz A, Kondrackiene J, Binder T, et al. 2012. Efficacy of ursodeoxycholic acid in treatingintrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 143:1492–1501.
   PubMed Web of Science ®Google Scholar
• Bicocca MJ, Sperling JD, Chauhan SP. 2018. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. European Journal of Obstetrics, Gynecology, and Reproductive Biology 231:180–187.
   PubMed Web of Science ®Google Scholar
• Chiang J. 2011. Bile acids metabolism. In: Monga SP, editor. Molecular pathology of liver diseases. New York (NY): Springer. p. 165–179.
   Google Scholar
• Clemente MG, De Virgiliis S, Kang JS, Macatagney R, Musu MP, Di Pierro MR, et al. 2003. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52:218–223.
   PubMed Web of Science ®Google Scholar
• Committee on Obstetric Practice. 2017. Committee opinion No. 713: antenatal corticosteroid therapy for fetal maturation. American College of Obstetrics and Gynecology 130:102–109.
   PubMed Web of Science ®Google Scholar
• Demir E, Ozkan H, Seckin KD, Sahtiyancı B, Demir B, Tabak O, et al. 2019. Plasma zonulin levels as a non-invasive biomarker of intestinal permeability in women with gestational diabetes mellitus. Biomolecules 9:24–30.
   PubMed Web of Science ®Google Scholar
• Edwards CJ. 2008. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. The Journal of Rheumatology 35:1477–14797.
   PubMed Web of Science ®Google Scholar
• Fasano A. 2001. Pathological and therapeutical implications of macromolecule passage through the tight junction. Tight junctions. Boca Raton (FL): CRC. p. 697–722.
   Google Scholar
• Fasano A. 2008. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. The American Journal of Pathology 173:1243–1252.
   PubMed Web of Science ®Google Scholar
• Fasano A. 2011. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiological Reviews 91:151–175.
   PubMed Web of Science ®Google Scholar
• Friberg AK, Zingmark V, Lyndrup J. 2016. Early induction of labor in high-risk intrahepatic cholestasis of pregnancy: what are the costs? Archives of Gynecology and Obstetrics 294:709–714.
   PubMed Web of Science ®Google Scholar
• Gabzdyl EM, Schlaeger JM. 2015. Intrahepatic cholestasis of pregnancy: a critical clinical review. The Journal of Perinatal & Neonatal Nursing 29:41–50.
   PubMed Web of Science ®Google Scholar
• Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C. 2014. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 59:1482–1491.
   PubMed Web of Science ®Google Scholar
• Geenes V, Lovgren-Sandblom A, Benthin L, Lawrance D, Cham-bers J, Gurung V, et al. 2014. The reversed feto-maternal bile acidgradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid. PLoS One. 9:e83828.
   PubMed Web of Science ®Google Scholar
• Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, et al. 2000. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunological Reviews 174:210–225.
   PubMed Web of Science ®Google Scholar
• Glantz A, Marschall HU, Mattsson LA. 2004. Intrahepatic cholestasisof pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40:467–474.
   PubMed Web of Science ®Google Scholar
• Groschwitz KR, Hogan SP. 2009. Intestinal barrier function: molecular regulation and disease pathogenesis. The Journal of Allergy and Clinical Immunology 124:3–20.
   PubMed Web of Science ®Google Scholar
• Kawakita T, Parikh LI, Ramsey PS, Huang CC, Zeymo A, Fernandez M, et al. 2015. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. American Journal of Obstetrics and Gynecology 213:570.e1.
   PubMed Web of Science ®Google Scholar
• Kim AS, Ko HJ. 2018. Plasma concentration of zonulin are elevated in obese men with fatty liver disease. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 11:149–157.
   PubMed Web of Science ®Google Scholar
• Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, et al. 2013. Increased plasma zonulin in patients with sepsis. Biochemia Medica 23:101–107.
   Web of Science ®Google Scholar
• Lee RH, Kwok KM, Ingles S, Wilson ML, Mullin P, Incerpi M, et al. 2008. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. American Journal of Perinatology 25:341–345.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li C, Huang M, Tong C, Zhang X, Wang L, et al. 2015. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial. BMC Gastroenterology 15:34–40.
   PubMed Web of Science ®Google Scholar
• Mäkelä M, Vaarala O, Hermann R, Salminen K, Vahlberg T, Veijola R, et al. 2006. Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin. Journal of Autoimmunity 27:54–61.
   PubMed Web of Science ®Google Scholar
• Marschall HU, Wikström Shemer E, Ludvigsson JF, Stephansson O. 2013. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology 58:1385–1391.
   PubMed Web of Science ®Google Scholar
• Mashige F, Tanaka N, Maki A, Kamei S, Yamanaka M. 1981. Direct spectrophotometry of total bile acids in serum. Clinical Chemistry 27:1352–1356.
   PubMed Web of Science ®Google Scholar
• Neuman MG. 2003. Cytokines—central factors in alcoholic liver disease. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism 27:307–316.
   PubMedGoogle Scholar
• Neuman MG, Angulo P, Malkiewicz I, Jorgensen R, Shear N, Dickson ER, et al. 2002. Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. Journal of Gastroenterology and Hepatology 17:196–202.
   PubMed Web of Science ®Google Scholar
• Reyes H, Zapata R, Hernández I, Gotteland M, Sandoval L, Jirón MI, et al. 2006. Is a leaky gut involved in the pathogenesis of intrahepatic cholestasis of pregnancy? Hepatology 43:715–722.
   PubMed Web of Science ®Google Scholar
• Roncaglia N, Locatelli A, Arreghini A, Assi F, Cameroni I, Pezzullo JC, et al. 2004. A randomised controlled trial of ursodeoxycholic acid and Sadenosyl-L-methionine in the treatment of gestational cholestasis. BJOG: An International Journal of Obstetrics and Gynaecology 111:17–21.
   PubMed Web of Science ®Google Scholar
• Rook M, Vargas J, Caughey A, Bacchetti P, Rosenthal P, Bull L. 2012. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. PLoS One. 7:e28343.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, et al. 2009. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proceedings of the National Academy of Sciences of the United States of America 106:16799–16804.
   PubMed Web of Science ®Google Scholar
• Úbeda M, Lario M, Muñoz L, Borrero MJ, Rodríguez-Serrano M, Sánchez-Díaz AM, et al. 2016. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats. Journal of Hepatology 64:1049–1057.
   PubMed Web of Science ®Google Scholar
• Watts T, Berti I, Sapone A, Gerarduzzi T, Not T, Zielke R, et al. 2005. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proceedings of the National Academy of Sciences of the United States of America 102:2912–2916.
   Web of Science ®Google Scholar
• Wikström Shemer EA, Stephansson O, Thuresson M, Thorsell M, Ludvigsson JF, Marschall HU. 2015. Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study. Journal of Hepatology 63:456–461.
   PubMed Web of Science ®Google Scholar
• Williamson C, Geenes V. 2014. Intrahepatic cholestasis of pregnancy. Obstetrics and Gynecology 124:120–133.
   PubMed Web of Science ®Google Scholar
• Yokote H, Miyake S, Croxford JL, Oki S, Mizusawa H, Yamamura T. 2008. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. The American Journal of Pathology 173:1714–1723.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fei L, Wang Y, Pitre A, Fang ZZ, Frank MW, et al. 2015. Maternal bile acid transporter deficiency promotes neonatal demise. Nature Communications 6:8186.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li F, Wang Y, Sentilhes L, Verspyck EPP, Marpeau L. 2006. Fetal death in a patient with intrahepatic cholestasis of pregnancy. Obstetrics & Gynecology 107:458–460.
   PubMed Web of Science ®Google Scholar